|
G |
CASP8 |
caspase 8 |
multiple interactions increases expression |
EXP |
TNFRSF1A mRNA promotes the reaction [marbofloxacin results in increased expression of CASP8 mRNA] |
CTD |
PMID:31005593 |
|
NCBI chr37:10,362,071...10,402,108
Ensembl chr37:10,391,048...10,401,822
|
|
G |
FADD |
Fas associated via death domain |
increases expression |
EXP |
marbofloxacin results in increased expression of FADD mRNA |
CTD |
PMID:31005593 |
|
NCBI chr18:48,087,447...48,094,497
|
|
G |
TNF |
tumor necrosis factor |
increases expression |
EXP |
marbofloxacin results in increased expression of TNF mRNA; marbofloxacin results in increased expression of TNF protein |
CTD |
PMID:31005593 |
|
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
multiple interactions increases expression |
EXP |
TNFRSF1A mRNA promotes the reaction [marbofloxacin results in increased expression of CASP8 mRNA]; TNFRSF1A mRNA promotes the reaction [marbofloxacin results in increased expression of TRADD mRNA] marbofloxacin results in increased expression of TNFRSF1A mRNA; marbofloxacin results in increased expression of TNFRSF1A protein |
CTD |
PMID:31005593 |
|
NCBI chr27:38,641,837...38,654,693
Ensembl chr27:38,638,753...38,700,282
|
|
G |
TRADD |
TNFRSF1A associated via death domain |
multiple interactions increases expression |
EXP |
TNFRSF1A mRNA promotes the reaction [marbofloxacin results in increased expression of TRADD mRNA] |
CTD |
PMID:31005593 |
|
NCBI chr 5:82,200,430...82,211,430
Ensembl chr 5:82,206,111...82,210,963
|
|
|
G |
ABCA5 |
ATP binding cassette subfamily A member 5 |
increases expression |
EXP |
masitinib results in increased expression of ABCA5 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 9:15,708,070...15,781,100
Ensembl chr 9:15,420,835...15,783,045
|
|
G |
ABHD14A |
abhydrolase domain containing 14A |
increases expression |
EXP |
masitinib results in increased expression of ABHD14A mRNA |
CTD |
PMID:22747577 |
|
NCBI chr20:37,738,500...37,744,689
|
|
G |
ABITRAM |
actin binding transcription modulator |
decreases expression |
EXP |
masitinib results in decreased expression of ABITRAM mRNA |
CTD |
PMID:22747577 |
|
NCBI chr11:64,094,653...64,100,078
Ensembl chr11:64,094,721...64,109,421
|
|
G |
ABLIM1 |
actin binding LIM protein 1 |
increases expression |
EXP |
masitinib results in increased expression of ABLIM1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr28:25,260,323...25,543,369
Ensembl chr28:25,260,873...25,545,304
|
|
G |
ACAT2 |
acetyl-CoA acetyltransferase 2 |
decreases expression |
EXP |
masitinib results in decreased expression of ACAT2 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 1:49,011,665...49,029,368
Ensembl chr 1:49,011,706...49,029,327
|
|
G |
ACSM3 |
acyl-CoA synthetase medium chain family member 3 |
increases expression |
EXP |
masitinib results in increased expression of ACSM3 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 6:24,558,010...24,594,326
Ensembl chr 6:24,558,142...24,582,728
|
|
G |
ACTL7A |
actin like 7A |
increases expression |
EXP |
masitinib results in increased expression of ACTL7A mRNA |
CTD |
PMID:22747577 |
|
NCBI chr11:64,031,305...64,033,908
Ensembl chr11:64,032,358...64,033,788
|
|
G |
ACTR2 |
actin related protein 2 |
decreases expression |
EXP |
masitinib results in decreased expression of ACTR2 protein |
CTD |
PMID:22747577 |
|
NCBI chr10:64,696,068...64,733,027
Ensembl chr10:64,696,111...64,730,553
|
|
G |
ADPRH |
ADP-ribosylarginine hydrolase |
increases expression |
EXP |
masitinib results in increased expression of ADPRH mRNA |
CTD |
PMID:22747577 |
|
NCBI chr33:23,218,633...23,226,844
Ensembl chr33:23,218,101...23,224,667
|
|
G |
AGA |
aspartylglucosaminidase |
increases expression |
EXP |
masitinib results in increased expression of AGA mRNA |
CTD |
PMID:22747577 |
|
NCBI chr16:52,314,860...52,324,879
Ensembl chr16:52,314,535...52,324,894
|
|
G |
AGO2 |
argonaute RISC catalytic component 2 |
decreases expression |
EXP |
masitinib results in decreased expression of AGO2 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr13:35,169,243...35,230,252
Ensembl chr13:35,180,912...35,268,577
|
|
G |
AGRN |
agrin |
increases expression |
EXP |
masitinib results in increased expression of AGRN mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 5:56,239,621...56,273,679
Ensembl chr 5:56,239,701...56,272,745
|
|
G |
AIG1 |
androgen induced 1 |
increases expression |
EXP |
masitinib results in increased expression of AIG1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 1:34,643,994...34,884,445
Ensembl chr 1:34,643,764...34,884,119
|
|
G |
ALAS2 |
5'-aminolevulinate synthase 2 |
increases expression |
EXP |
masitinib results in increased expression of ALAS2 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr X:46,703,477...46,731,767
Ensembl chr X:46,703,477...46,723,529
|
|
G |
ALDH5A1 |
aldehyde dehydrogenase 5 family member A1 |
decreases expression |
EXP |
masitinib results in decreased expression of ALDH5A1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr35:22,560,005...22,590,996
Ensembl chr35:22,560,008...22,587,875
|
|
G |
AMN1 |
antagonist of mitotic exit network 1 homolog |
increases expression |
EXP |
masitinib results in increased expression of AMN1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr27:17,044,301...17,100,444
Ensembl chr27:17,044,309...17,361,570
|
|
G |
ANKRD26 |
ankyrin repeat domain containing 26 |
increases expression |
EXP |
masitinib results in increased expression of ANKRD26 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 2:6,230,466...6,402,360
|
|
G |
ANP32E |
acidic nuclear phosphoprotein 32 family member E |
decreases expression |
EXP |
masitinib results in decreased expression of ANP32E mRNA |
CTD |
PMID:22747577 |
|
NCBI chr17:59,460,864...59,482,467
Ensembl chr17:59,462,766...59,477,936
|
|
G |
ANXA1 |
annexin A1 |
increases expression |
EXP |
masitinib results in increased expression of ANXA1 protein |
CTD |
PMID:22747577 |
|
NCBI chr 1:84,744,159...84,763,011
Ensembl chr 1:84,744,163...84,763,011
|
|
G |
ANXA6 |
annexin A6 |
increases expression |
EXP |
masitinib results in increased expression of ANXA6 protein |
CTD |
PMID:22747577 |
|
NCBI chr 4:58,091,186...58,140,102
Ensembl chr 4:58,091,251...58,139,372
|
|
G |
ARMC12 |
armadillo repeat containing 12 |
increases expression |
EXP |
masitinib results in increased expression of ARMC12 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr12:4,868,831...4,879,801
Ensembl chr12:4,869,774...4,879,793
|
|
G |
ASCC1 |
activating signal cointegrator 1 complex subunit 1 |
decreases expression |
EXP |
masitinib results in decreased expression of ASCC1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 4:22,779,644...22,876,434
Ensembl chr 4:22,779,781...22,874,215
|
|
G |
B4GALT7 |
beta-1,4-galactosyltransferase 7 |
increases expression |
EXP |
masitinib results in increased expression of B4GALT7 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr11:3,497,860...3,507,513
Ensembl chr11:3,498,153...3,505,034
|
|
G |
BIRC5 |
baculoviral IAP repeat containing 5 |
decreases expression |
EXP |
masitinib results in decreased expression of BIRC5 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 9:2,930,308...2,959,307
|
|
G |
BTBD3 |
BTB domain containing 3 |
decreases expression |
EXP |
masitinib results in decreased expression of BTBD3 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr24:10,478,635...10,512,773
Ensembl chr24:10,479,900...10,512,185
|
|
G |
CA2 |
carbonic anhydrase 2 |
decreases expression |
EXP |
masitinib results in decreased expression of CA2 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr29:31,959,225...31,975,309
Ensembl chr29:31,935,172...31,980,579
|
|
G |
CAMK2G |
calcium/calmodulin dependent protein kinase II gamma |
increases expression |
EXP |
masitinib results in increased expression of CAMK2G mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 4:24,244,063...24,299,362
Ensembl chr 4:24,245,960...24,299,357
|
|
G |
CAPG |
capping actin protein, gelsolin like |
increases expression |
EXP |
masitinib results in increased expression of CAPG protein |
CTD |
PMID:22747577 |
|
NCBI chr17:39,619,429...39,640,944
Ensembl chr17:39,619,248...39,640,942
|
|
G |
CCT2 |
chaperonin containing TCP1 subunit 2 |
decreases expression |
EXP |
masitinib results in decreased expression of CCT2 protein |
CTD |
PMID:22747577 |
|
NCBI chr10:11,560,287...11,586,559
Ensembl chr10:11,560,396...11,578,433
|
|
G |
CD5L |
CD5 molecule like |
increases expression |
EXP |
masitinib results in increased expression of CD5L mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 7:40,516,190...40,526,528
Ensembl chr 7:40,516,190...40,526,528
|
|
G |
CDADC1 |
cytidine and dCMP deaminase domain containing 1 |
increases expression |
EXP |
masitinib results in increased expression of CDADC1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr22:2,443,459...2,489,147
Ensembl chr22:2,436,206...2,489,016
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
increases expression |
EXP |
masitinib results in increased expression of CDKN1A mRNA |
CTD |
PMID:22747577 |
|
NCBI chr12:5,746,898...5,755,103
Ensembl chr12:5,745,852...5,892,281
|
|
G |
CIAPIN1 |
cytokine induced apoptosis inhibitor 1 |
decreases expression |
EXP |
masitinib results in decreased expression of CIAPIN1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 2:58,977,592...58,992,785
Ensembl chr 2:58,977,676...58,992,581
|
|
G |
CIRBP |
cold inducible RNA binding protein |
increases expression |
EXP |
masitinib results in increased expression of CIRBP mRNA |
CTD |
PMID:22747577 |
|
NCBI chr20:57,521,609...57,526,526
Ensembl chr20:57,519,119...57,526,435
|
|
G |
CLEC2B |
C-type lectin domain family 2 member B |
decreases expression |
EXP |
masitinib results in decreased expression of CLEC2B mRNA |
CTD |
PMID:22747577 |
|
NCBI chr27:36,088,754...36,143,581
Ensembl chr27:36,120,134...36,143,040
|
|
G |
CMTM7 |
CKLF like MARVEL transmembrane domain containing 7 |
increases expression |
EXP |
masitinib results in increased expression of CMTM7 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr23:12,317,636...12,382,836
Ensembl chr23:12,328,303...12,382,837
|
|
G |
CORO1A |
coronin 1A |
increases expression |
EXP |
masitinib results in increased expression of CORO1A protein |
CTD |
PMID:22747577 |
|
NCBI chr 6:18,161,850...18,167,915
Ensembl chr 6:18,160,601...18,167,818
|
|
G |
CPNE1 |
copine 1 |
increases expression |
EXP |
masitinib results in increased expression of CPNE1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr24:24,554,636...24,589,748
Ensembl chr24:24,554,636...24,589,731
|
|
G |
CPNE6 |
copine 6 |
increases expression |
EXP |
masitinib results in increased expression of DHRS4 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
|
|
G |
CTSK |
cathepsin K |
increases expression |
EXP |
masitinib results in increased expression of CTSK mRNA |
CTD |
PMID:22747577 |
|
NCBI chr17:59,928,725...59,938,293
Ensembl chr17:59,929,287...59,938,507
|
|
G |
DLA-12 |
MHC class I DLA-12 |
increases expression |
EXP |
masitinib results in increased expression of DLA-12 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr12:933,321...936,671
Ensembl chr12:932,613...987,561
|
|
G |
DLA-64 |
MHC class I DLA-64 |
increases expression |
EXP |
masitinib results in increased expression of DLA-64 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr12:983,573...986,969
|
|
G |
DLGAP1 |
DLG associated protein 1 |
decreases expression |
EXP |
masitinib results in decreased expression of DLGAP1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 7:70,082,563...70,949,116
Ensembl chr 7:70,081,885...70,406,213
|
|
G |
DLGAP5 |
DLG associated protein 5 |
decreases expression |
EXP |
masitinib results in decreased expression of DLGAP5 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 8:30,998,806...31,038,614
Ensembl chr 8:30,994,402...31,036,540
|
|
G |
DPCD |
deleted in primary ciliary dyskinesia homolog |
decreases expression |
EXP |
masitinib results in decreased expression of DPCD mRNA |
CTD |
PMID:22747577 |
|
NCBI chr28:14,201,302...14,219,121
Ensembl chr28:14,201,351...14,219,121
|
|
G |
DPYSL3 |
dihydropyrimidinase like 3 |
decreases expression |
EXP |
masitinib results in decreased expression of DPYSL3 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 2:41,687,725...41,809,402
Ensembl chr 2:41,690,845...41,802,376
|
|
G |
EBPL |
EBP like |
increases expression |
EXP |
masitinib results in increased expression of EBPL mRNA |
CTD |
PMID:22747577 |
|
NCBI chr22:2,116,588...2,137,935
Ensembl chr22:2,116,131...2,182,633
|
|
G |
EDEM2 |
ER degradation enhancing alpha-mannosidase like protein 2 |
increases expression |
EXP |
masitinib results in increased expression of EDEM2 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr24:24,137,228...24,165,995
Ensembl chr24:24,137,228...24,165,968
|
|
G |
EIF3A |
eukaryotic translation initiation factor 3 subunit A |
decreases expression |
EXP |
masitinib results in decreased expression of EIF3A protein |
CTD |
PMID:22747577 |
|
NCBI chr28:29,290,668...29,326,851
Ensembl chr28:29,291,422...29,326,701
|
|
G |
EIF4A1 |
eukaryotic translation initiation factor 4A1 |
decreases expression |
EXP |
masitinib results in decreased expression of EIF4A1 protein |
CTD |
PMID:22747577 |
|
NCBI chr 5:32,495,606...32,500,805
Ensembl chr 5:32,484,572...32,500,805
|
|
G |
EIF5A2 |
eukaryotic translation initiation factor 5A2 |
decreases expression |
EXP |
masitinib results in decreased expression of EIF5A2 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr34:35,309,812...35,322,382
Ensembl chr34:35,314,172...35,322,392
|
|
G |
ELSPBP1 |
epididymal sperm binding protein 1 |
increases expression |
EXP |
masitinib results in increased expression of ELSPBP1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 1:108,159,609...108,187,224
Ensembl chr 1:108,159,611...108,188,076
|
|
G |
ETFDH |
electron transfer flavoprotein dehydrogenase |
decreases expression |
EXP |
masitinib results in decreased expression of ETFDH mRNA |
CTD |
PMID:22747577 |
|
NCBI chr15:55,752,170...55,781,118
Ensembl chr15:55,752,200...55,792,105
|
|
G |
GGT1 |
gamma-glutamyltransferase 1 |
increases expression |
EXP |
masitinib results in increased expression of GGT1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr26:28,301,455...28,315,029
|
|
G |
GKN1 |
gastrokine 1 |
increases expression |
EXP |
masitinib results in increased expression of GKN1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr10:67,788,329...67,793,445
Ensembl chr10:67,788,110...67,793,589
|
|
G |
GMFB |
glia maturation factor beta |
decreases expression |
EXP |
masitinib results in decreased expression of GMFB mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 8:30,394,020...30,408,408
Ensembl chr 8:30,359,499...30,408,357
|
|
G |
GSTA4 |
glutathione S-transferase alpha 4 |
increases expression |
EXP |
masitinib results in increased expression of GSTA4 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr12:20,426,724...20,443,200
Ensembl chr12:20,426,726...20,443,200
|
|
G |
GXYLT1 |
glucoside xylosyltransferase 1 |
decreases expression |
EXP |
masitinib results in decreased expression of GXYLT1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr27:11,754,609...11,810,245
Ensembl chr27:11,765,072...11,807,787
|
|
G |
HEBP2 |
heme binding protein 2 |
decreases expression |
EXP |
masitinib results in decreased expression of HEBP2 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 1:30,716,395...30,724,814
Ensembl chr 1:30,716,606...30,724,613
|
|
G |
HERPUD1 |
homocysteine inducible ER protein with ubiquitin like domain 1 |
increases expression |
EXP |
masitinib results in increased expression of HERPUD1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 2:59,388,492...59,400,028
Ensembl chr 2:59,388,494...59,400,003
|
|
G |
HSP90B1 |
heat shock protein 90 beta family member 1 |
increases expression |
EXP |
masitinib results in increased expression of HSP90B1 protein |
CTD |
PMID:22747577 |
|
NCBI chr15:42,456,793...42,474,122
Ensembl chr15:42,456,764...42,579,311
|
|
G |
HTR2B |
5-hydroxytryptamine receptor 2B |
increases expression |
EXP |
masitinib results in increased expression of HTR2B mRNA |
CTD |
PMID:22747577 |
|
NCBI chr25:43,042,306...43,056,361
Ensembl chr25:43,042,173...43,056,612
|
|
G |
HYAL3 |
hyaluronidase 3 |
increases expression |
EXP |
masitinib results in increased expression of HYAL3 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr20:39,041,940...39,047,388
Ensembl chr20:39,042,070...39,047,365
|
|
G |
IGFBP7 |
insulin like growth factor binding protein 7 |
increases expression |
EXP |
masitinib results in increased expression of IGFBP7 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr13:49,138,406...49,207,235
Ensembl chr13:49,138,402...49,207,394
|
|
G |
IL13 |
interleukin 13 |
increases expression |
EXP |
masitinib results in increased expression of IL13 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr11:20,957,870...20,961,391
Ensembl chr11:20,958,464...20,961,388
|
|
G |
IMMP2L |
inner mitochondrial membrane peptidase subunit 2 |
increases expression |
EXP |
masitinib results in increased expression of IMMP2L mRNA |
CTD |
PMID:22747577 |
|
NCBI chr14:50,487,679...51,336,906
|
|
G |
IRX6 |
iroquois homeobox 6 |
increases expression |
EXP |
masitinib results in increased expression of IRX6 protein |
CTD |
PMID:22747577 |
|
NCBI chr 2:60,630,688...60,636,285
Ensembl chr 2:60,630,447...60,636,416
|
|
G |
ITGA6 |
integrin subunit alpha 6 |
decreases expression |
EXP |
masitinib results in decreased expression of ITGA6 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr36:16,777,363...16,858,725
Ensembl chr36:16,776,863...16,855,449
|
|
G |
JAML |
junction adhesion molecule like |
decreases expression |
EXP |
masitinib results in decreased expression of JAML mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 5:15,485,378...15,513,457
Ensembl chr 5:15,476,582...15,513,075
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP |
masitinib results in increased expression of JUN mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 5:50,966,698...50,968,939
|
|
G |
KCTD19 |
potassium channel tetramerization domain containing 19 |
increases expression |
EXP |
masitinib results in increased expression of KCTD19 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 5:82,060,946...82,093,248
Ensembl chr 5:82,061,449...82,093,246
|
|
G |
KLHL5 |
kelch like family member 5 |
increases expression |
EXP |
masitinib results in increased expression of KLHL5 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 3:73,258,925...73,347,262
Ensembl chr 3:73,262,895...73,344,879
|
|
G |
LBX2 |
ladybird homeobox 2 |
increases expression |
EXP |
masitinib results in increased expression of LBX2 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr17:48,641,630...48,643,411
Ensembl chr17:48,641,674...48,643,239
|
|
G |
LIN7C |
lin-7 homolog C, crumbs cell polarity complex component |
decreases expression |
EXP |
masitinib results in decreased expression of LIN7C mRNA |
CTD |
PMID:22747577 |
|
NCBI chr21:48,061,446...48,071,458
Ensembl chr21:48,064,929...48,071,429
|
|
G |
LOC474850 |
heat shock 70 kDa protein 1-like |
increases expression |
EXP |
masitinib results in increased expression of HSPA1L mRNA |
CTD |
PMID:22747577 |
|
NCBI chr12:1,281,164...1,285,010
Ensembl chr12:1,281,472...1,285,440
|
|
G |
LOC475707 |
GPN-loop GTPase 1 |
decreases expression |
EXP |
masitinib results in decreased expression of GPN1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr17:21,654,516...21,678,435
Ensembl chr17:21,545,673...21,673,157
|
|
G |
LOC478000 |
phytanoyl-CoA hydroxylase-like |
increases expression |
EXP |
masitinib results in increased expression of PHYH mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 2:23,185,901...23,206,719
Ensembl chr 2:23,185,782...23,253,497
|
|
G |
LOC609402 |
hemoglobin subunit beta-like |
increases expression |
EXP |
masitinib results in increased expression of HBG1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr21:28,187,535...28,188,991
|
|
G |
LONRF1 |
LON peptidase N-terminal domain and ring finger 1 |
increases expression |
EXP |
masitinib results in increased expression of LONRF1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr16:36,220,324...36,256,896
Ensembl chr16:36,221,156...36,256,897
|
|
G |
LRP1 |
LDL receptor related protein 1 |
increases expression |
EXP |
masitinib results in increased expression of LRP1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr10:1,260,256...1,341,705
Ensembl chr10:1,260,719...1,352,271
|
|
G |
LRP8 |
LDL receptor related protein 8 |
decreases expression |
EXP |
masitinib results in decreased expression of LRP8 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 5:55,604,878...55,684,666
Ensembl chr 5:55,604,878...55,699,736
|
|
G |
LYRM1 |
LYR motif containing 1 |
increases expression |
EXP |
masitinib results in increased expression of LYRM1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 6:24,428,461...24,460,291
Ensembl chr 6:24,441,307...24,460,331
|
|
G |
MAGEF1 |
MAGE family member F1 |
decreases expression |
EXP |
masitinib results in decreased expression of MAGEF1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr34:17,543,381...17,545,089
Ensembl chr34:17,543,906...17,544,868
|
|
G |
MOB1B |
MOB kinase activator 1B |
decreases expression |
EXP |
masitinib results in decreased expression of MOB1B mRNA |
CTD |
PMID:22747577 |
|
NCBI chr13:60,145,168...60,197,916
Ensembl chr13:60,145,366...60,195,463
|
|
G |
MPDZ |
multiple PDZ domain crumbs cell polarity complex component |
increases expression |
EXP |
masitinib results in increased expression of MPDZ mRNA |
CTD |
PMID:22747577 |
|
NCBI chr11:33,691,434...33,826,500
Ensembl chr11:33,692,296...33,826,437
|
|
G |
MYOZ1 |
myozenin 1 |
increases expression |
EXP |
masitinib results in increased expression of MYOZ1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 4:24,158,532...24,165,416
Ensembl chr 4:24,158,720...24,165,392
|
|
G |
NAPG |
NSF attachment protein gamma |
decreases expression |
EXP |
masitinib results in decreased expression of NAPG mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 7:76,403,561...76,424,994
Ensembl chr 7:76,403,595...76,423,170
|
|
G |
NDUFS1 |
NADH:ubiquinone oxidoreductase core subunit S1 |
decreases expression |
EXP |
masitinib results in decreased expression of NDUFS1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr37:14,680,908...14,713,838
Ensembl chr37:14,683,083...14,713,754
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
increases expression |
EXP |
masitinib results in increased expression of NFKBIA mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 8:14,100,203...14,103,453
Ensembl chr 8:14,100,671...14,103,433
|
|
G |
NRAS |
NRAS proto-oncogene, GTPase |
decreases expression |
EXP |
masitinib results in decreased expression of NRAS mRNA |
CTD |
PMID:22747577 |
|
NCBI chr17:52,411,733...52,418,788
Ensembl chr17:52,411,733...52,418,788
|
|
G |
NSG1 |
neuronal vesicle trafficking associated 1 |
decreases expression |
EXP |
masitinib results in decreased expression of NSG1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 3:69,805,646...69,831,200
Ensembl chr 3:69,805,592...69,831,194
|
|
G |
NTRK1 |
neurotrophic receptor tyrosine kinase 1 |
increases expression |
EXP |
masitinib results in increased expression of NTRK1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 7:41,140,931...41,159,326
Ensembl chr 7:41,140,879...41,159,288
|
|
G |
OCA2 |
OCA2 melanosomal transmembrane protein |
decreases expression |
EXP |
masitinib results in decreased expression of OCA2 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 3:32,361,825...32,713,631
Ensembl chr 3:32,361,517...32,713,572
|
|
G |
OGT |
O-linked N-acetylglucosamine (GlcNAc) transferase |
increases expression |
EXP |
masitinib results in increased expression of OGT mRNA |
CTD |
PMID:22747577 |
|
NCBI chr X:55,821,227...55,857,597
Ensembl chr X:55,821,234...55,855,502
|
|
G |
OXCT1 |
3-oxoacid CoA-transferase 1 |
increases expression |
EXP |
masitinib results in increased expression of OXCT1 protein |
CTD |
PMID:22747577 |
|
NCBI chr 4:67,709,846...67,841,737
Ensembl chr 4:67,527,531...67,841,518
|
|
G |
PARP14 |
poly(ADP-ribose) polymerase family member 14 |
increases expression |
EXP |
masitinib results in increased expression of PARP14 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr33:25,763,282...25,798,284
Ensembl chr33:25,763,255...25,798,198
|
|
G |
PCM1 |
pericentriolar material 1 |
increases expression |
EXP |
masitinib results in increased expression of PCM1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr16:41,212,733...41,291,654
Ensembl chr16:41,214,417...41,291,376
|
|
G |
PCOLCE2 |
procollagen C-endopeptidase enhancer 2 |
decreases expression |
EXP |
masitinib results in decreased expression of PCOLCE2 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr23:38,424,408...38,486,800
Ensembl chr23:38,426,216...38,487,252
|
|
G |
PDE6H |
phosphodiesterase 6H |
increases expression |
EXP |
masitinib results in increased expression of PDE6H mRNA |
CTD |
PMID:22747577 |
|
NCBI chr27:31,640,731...31,664,494
Ensembl chr27:31,640,737...31,664,401
|
|
G |
PDHA1 |
pyruvate dehydrogenase E1 subunit alpha 1 |
decreases expression |
EXP |
masitinib results in decreased expression of PDHA1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr X:15,338,364...15,354,011
Ensembl chr X:15,338,202...15,387,458
|
|
G |
PDIA3 |
protein disulfide isomerase family A member 3 |
increases expression |
EXP |
masitinib results in increased expression of PDIA3 protein |
CTD |
PMID:22747577 |
|
NCBI chr30:10,487,926...10,513,437
Ensembl chr30:10,487,921...10,513,397
|
|
G |
PEBP4 |
phosphatidylethanolamine binding protein 4 |
increases expression |
EXP |
masitinib results in increased expression of PEBP4 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr25:34,329,160...34,574,086
Ensembl chr25:34,317,421...34,574,066
|
|
G |
PECAM1 |
platelet and endothelial cell adhesion molecule 1 |
increases expression |
EXP |
masitinib results in increased expression of PECAM1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 9:12,166,124...12,219,553
Ensembl chr 9:12,166,775...12,219,778
|
|
G |
PHF10 |
PHD finger protein 10 |
increases expression |
EXP |
masitinib results in increased expression of PHF10 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr12:71,955,354...71,998,283
Ensembl chr12:71,787,082...71,998,243
|
|
G |
POMT1 |
protein O-mannosyltransferase 1 |
decreases expression |
EXP |
masitinib results in decreased expression of POMT1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 9:52,615,349...52,631,538
Ensembl chr 9:52,615,655...52,630,836
|
|
G |
POR |
cytochrome p450 oxidoreductase |
increases expression |
EXP |
masitinib results in increased expression of POR mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 6:7,247,780...7,316,282
Ensembl chr 6:7,263,574...7,316,297
|
|
G |
PPA1 |
inorganic pyrophosphatase 1 |
decreases expression |
EXP |
masitinib results in decreased expression of PPA1 protein |
CTD |
PMID:22747577 |
|
NCBI chr 4:21,145,547...21,189,985
Ensembl chr 4:21,145,547...21,182,748
|
|
G |
PRPS2 |
phosphoribosyl pyrophosphate synthetase 2 |
decreases expression |
EXP |
masitinib results in decreased expression of PRPS2 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr X:9,281,686...9,326,551
Ensembl chr X:9,281,730...9,418,289
|
|
G |
PSMB9 |
proteasome 20S subunit beta 9 |
increases expression |
EXP |
masitinib results in increased expression of PSMB9 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr12:2,432,287...2,438,920
Ensembl chr12:2,432,505...2,438,069
|
|
G |
PSMD6 |
proteasome 26S subunit, non-ATPase 6 |
decreases expression |
EXP |
masitinib results in decreased expression of PSMD6 protein |
CTD |
PMID:22747577 |
|
NCBI chr20:27,206,801...27,220,059
|
|
G |
PSMD9 |
proteasome 26S subunit, non-ATPase 9 |
decreases expression |
EXP |
masitinib results in decreased expression of PSMD9 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr26:7,376,154...7,400,655
Ensembl chr26:7,377,413...7,400,573
|
|
G |
PTH |
parathyroid hormone |
increases expression |
EXP |
masitinib results in increased expression of PTH mRNA |
CTD |
PMID:22747577 |
|
NCBI chr21:36,417,062...36,419,967
Ensembl chr21:36,417,058...36,419,967
|
|
G |
PXYLP1 |
2-phosphoxylose phosphatase 1 |
decreases expression |
EXP |
masitinib results in decreased expression of ACPL2 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr23:37,145,065...37,197,808
Ensembl chr23:37,145,086...37,196,427
|
|
G |
R3HDM2 |
R3H domain containing 2 |
increases expression |
EXP |
masitinib results in increased expression of R3HDM2 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr10:1,377,664...1,504,008
Ensembl chr10:1,370,350...1,504,017
|
|
G |
RAB44 |
RAB44, member RAS oncogene family |
increases expression |
EXP |
masitinib results in increased expression of RAB44 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr12:5,769,056...5,804,963
Ensembl chr12:5,770,882...5,804,949
|
|
G |
RASGRP2 |
RAS guanyl releasing protein 2 |
increases expression |
EXP |
masitinib results in increased expression of RASGRP2 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr18:52,412,331...52,426,910
Ensembl chr18:52,412,367...52,426,916
|
|
G |
RCAN1 |
regulator of calcineurin 1 |
increases expression |
EXP |
masitinib results in increased expression of RCAN1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr31:29,908,046...30,002,412
Ensembl chr31:29,909,388...30,002,418
|
|
G |
RGS13 |
regulator of G protein signaling 13 |
decreases expression |
EXP |
masitinib results in decreased expression of RGS13 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr38:6,291,146...6,316,662
Ensembl chr38:6,291,182...6,315,198
|
|
G |
SAR1A |
secretion associated Ras related GTPase 1A |
decreases expression |
EXP |
masitinib results in decreased expression of SAR1A mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 4:21,120,788...21,136,409
Ensembl chr 4:21,123,028...21,136,973
|
|
G |
SCD |
stearoyl-CoA desaturase |
decreases expression |
EXP |
masitinib results in decreased expression of SCD mRNA |
CTD |
PMID:22747577 |
|
NCBI chr28:13,112,741...13,129,129
Ensembl chr28:13,113,006...13,125,801
|
|
G |
SELENBP1 |
selenium binding protein 1 |
increases expression |
EXP |
masitinib results in increased expression of SELENBP1 protein |
CTD |
PMID:22747577 |
|
NCBI chr17:60,410,727...60,418,770
Ensembl chr17:60,410,734...60,418,704
|
|
G |
SERPINE2 |
serpin family E member 2 |
increases expression |
EXP |
masitinib results in increased expression of SERPINE2 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr37:29,699,551...29,750,151
Ensembl chr37:29,700,024...29,724,228
|
|
G |
SFT2D2 |
SFT2 domain containing 2 |
decreases expression |
EXP |
masitinib results in decreased expression of SFT2D2 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 7:30,258,748...30,281,371
|
|
G |
SLA |
Src like adaptor |
increases expression |
EXP |
masitinib results in increased expression of SLA mRNA |
CTD |
PMID:22747577 |
|
NCBI chr13:29,503,304...29,590,679
Ensembl chr13:29,504,867...29,569,773
|
|
G |
SLC25A12 |
solute carrier family 25 member 12 |
decreases expression |
EXP |
masitinib results in decreased expression of SLC25A12 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr36:16,185,011...16,391,080
Ensembl chr36:16,185,649...16,483,016
|
|
G |
SMC5 |
structural maintenance of chromosomes 5 |
decreases expression |
EXP |
masitinib results in decreased expression of SMC5 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 1:87,192,988...87,285,678
Ensembl chr 1:87,194,867...87,285,606
|
|
G |
SRR |
serine racemase |
increases expression |
EXP |
masitinib results in increased expression of SRR mRNA |
CTD |
PMID:22747577 |
|
|
|
G |
STING1 |
stimulator of interferon response cGAMP interactor 1 |
increases expression |
EXP |
masitinib results in increased expression of TMEM173 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 2:34,783,947...34,792,204
Ensembl chr 2:34,784,232...34,789,072
|
|
G |
STOX1 |
storkhead box 1 |
increases expression |
EXP |
masitinib results in increased expression of STOX1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 4:20,013,893...20,065,480
Ensembl chr 4:20,014,007...20,060,394
|
|
G |
STX16 |
syntaxin 16 |
increases expression |
EXP |
masitinib results in increased expression of STX16 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr24:43,425,719...43,451,828
Ensembl chr24:43,426,470...43,449,077
|
|
G |
STYXL1 |
serine/threonine/tyrosine interacting like 1 |
increases expression |
EXP |
masitinib results in increased expression of STYXL1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 6:7,323,911...7,389,878
Ensembl chr 6:7,316,477...7,389,842
|
|
G |
TARDBP |
TAR DNA binding protein |
decreases expression |
EXP |
masitinib results in decreased expression of TARDBP protein |
CTD |
PMID:22747577 |
|
NCBI chr 2:84,987,752...84,998,136
Ensembl chr 2:84,989,952...84,998,593
|
|
G |
TBC1D14 |
TBC1 domain family member 14 |
decreases expression |
EXP |
masitinib results in decreased expression of TBC1D14 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 3:58,992,743...59,097,581
Ensembl chr 3:58,926,237...59,097,621
|
|
G |
TCN2 |
transcobalamin 2 |
increases expression |
EXP |
masitinib results in increased expression of TCN2 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr26:23,693,664...23,710,342
Ensembl chr26:23,693,773...23,709,832
|
|
G |
TCP1 |
t-complex 1 |
decreases expression |
EXP |
masitinib results in decreased expression of TCP1 protein |
CTD |
PMID:22747577 |
|
NCBI chr 1:49,029,260...49,038,023
Ensembl chr 1:49,029,282...49,038,020
|
|
G |
TEAD4 |
TEA domain transcription factor 4 |
increases expression |
EXP |
masitinib results in increased expression of TEAD4 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr27:41,744,100...41,783,223
Ensembl chr27:41,748,871...41,803,556
|
|
G |
THEMIS2 |
thymocyte selection associated family member 2 |
decreases expression |
EXP |
masitinib results in decreased expression of THEMIS2 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 2:72,465,719...72,501,962
Ensembl chr 2:72,464,026...72,502,928
|
|
G |
TM2D2 |
TM2 domain containing 2 |
increases expression |
EXP |
masitinib results in increased expression of TM2D2 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr16:26,551,563...26,557,554
Ensembl chr16:26,551,628...26,556,285
|
|
G |
TMEM108 |
transmembrane protein 108 |
increases expression |
EXP |
masitinib results in increased expression of TMEM108 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr23:29,992,038...30,331,791
Ensembl chr23:29,992,021...30,396,840
|
|
G |
TMEM260 |
transmembrane protein 260 |
increases expression |
EXP |
masitinib results in increased expression of TMEM260 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 8:32,238,992...32,309,320
Ensembl chr 8:32,238,988...32,306,317
|
|
G |
TNFSF10 |
TNF superfamily member 10 |
increases expression |
EXP |
masitinib results in increased expression of TNFSF10 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr34:36,719,249...36,734,989
Ensembl chr34:36,670,849...36,735,060
|
|
G |
TNPO1 |
transportin 1 |
decreases expression |
EXP |
masitinib results in decreased expression of TNPO1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 2:55,795,737...55,859,366
Ensembl chr 2:55,799,907...55,851,213
|
|
G |
TNS1 |
tensin 1 |
decreases expression |
EXP |
masitinib results in decreased expression of TNS1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr37:24,578,855...24,776,153
Ensembl chr37:24,581,806...24,808,049
|
|
G |
TOX |
thymocyte selection associated high mobility group box |
increases expression |
EXP |
masitinib results in increased expression of TOX mRNA |
CTD |
PMID:22747577 |
|
NCBI chr29:9,542,471...9,841,759
Ensembl chr29:9,544,561...9,842,034
|
|
G |
TSHB |
thyroid stimulating hormone subunit beta |
increases expression |
EXP |
masitinib results in increased expression of TSHB mRNA |
CTD |
PMID:22747577 |
|
NCBI chr17:52,659,137...52,685,388
Ensembl chr17:52,681,357...52,685,390
|
|
G |
TSPAN2 |
tetraspanin 2 |
increases expression |
EXP |
masitinib results in increased expression of TSPAN2 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr17:52,692,744...52,749,048
Ensembl chr17:52,694,603...52,744,276
|
|
G |
TTC38 |
tetratricopeptide repeat domain 38 |
increases expression |
EXP |
masitinib results in increased expression of TTC38 protein |
CTD |
PMID:22747577 |
|
NCBI chr10:19,887,285...19,910,347
Ensembl chr10:19,773,373...19,910,683
|
|
G |
TTLL1 |
TTL family tubulin polyglutamylase complex subunit L1 |
decreases expression |
EXP |
masitinib results in decreased expression of TTLL1 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr10:22,456,150...22,492,375
Ensembl chr10:22,456,146...22,488,505
|
|
G |
UCHL3 |
ubiquitin C-terminal hydrolase L3 |
increases expression |
EXP |
masitinib results in increased expression of UCHL3 protein |
CTD |
PMID:22747577 |
|
NCBI chr22:29,348,962...29,397,944
Ensembl chr22:29,348,706...29,407,965
|
|
G |
UQCC1 |
ubiquinol-cytochrome c reductase complex assembly factor 1 |
decreases expression |
EXP |
masitinib results in decreased expression of UQCC mRNA |
CTD |
PMID:22747577 |
|
NCBI chr24:24,285,147...24,381,819
Ensembl chr24:24,286,320...24,381,699
|
|
G |
UROD |
uroporphyrinogen decarboxylase |
increases expression |
EXP |
masitinib results in increased expression of UROD protein |
CTD |
PMID:22747577 |
|
NCBI chr15:15,313,808...15,317,130
Ensembl chr15:15,312,674...15,320,010
|
|
G |
UROS |
uroporphyrinogen III synthase |
increases expression |
EXP |
masitinib results in increased expression of UROS mRNA |
CTD |
PMID:22747577 |
|
NCBI chr28:34,952,074...34,983,532
Ensembl chr28:34,948,003...34,983,532
|
|
G |
VCPKMT |
valosin containing protein lysine methyltransferase |
decreases expression |
EXP |
masitinib results in decreased expression of VCPKMT mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 8:26,611,333...26,636,700
Ensembl chr 8:26,625,677...26,636,316
|
|
G |
WAPL |
WAPL cohesin release factor |
decreases expression |
EXP |
masitinib results in decreased expression of WAPAL mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 4:34,219,644...34,297,456
Ensembl chr 4:34,219,645...34,302,839
|
|
G |
YWHAZ |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta |
increases expression |
EXP |
masitinib results in increased expression of YWHAZ protein |
CTD |
PMID:22747577 |
|
NCBI chr13:2,729,404...2,764,422
|
|
G |
ZNF23 |
zinc finger protein 23 |
increases expression |
EXP |
masitinib results in increased expression of ZNF23 mRNA |
CTD |
PMID:22747577 |
|
NCBI chr 5:77,246,374...77,260,761
Ensembl chr 5:77,246,667...77,260,350
|
|
|
G |
CAPN1 |
calpain 1 |
increases expression |
EXP |
Ofloxacin results in increased expression of CAPN1 mRNA |
CTD |
PMID:24582689 |
|
NCBI chr18:51,983,266...52,010,831
Ensembl chr18:51,983,824...52,010,757
|
|
G |
CASP12 |
caspase 12 |
increases expression |
EXP |
Ofloxacin results in increased expression of CASP12 mRNA; Ofloxacin results in increased expression of CASP12 protein |
CTD |
PMID:24582689 |
|
NCBI chr 5:27,162,840...27,176,964
Ensembl chr 5:27,161,700...27,177,683
|
|
G |
CASP8 |
caspase 8 |
multiple interactions increases expression |
EXP |
TNFRSF1A mutant form inhibits the reaction [Ofloxacin results in increased expression of CASP8 mRNA] |
CTD |
PMID:24582689 |
|
NCBI chr37:10,362,071...10,402,108
Ensembl chr37:10,391,048...10,401,822
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
increases expression |
EXP |
Ofloxacin results in increased expression of DDIT3 mRNA |
CTD |
PMID:24582689 |
|
NCBI chr10:1,606,693...1,612,410
Ensembl chr10:1,606,693...1,611,303
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
increases expression |
EXP |
Ofloxacin results in increased expression of HSPA5 mRNA |
CTD |
PMID:24582689 |
|
NCBI chr 9:57,850,870...57,855,607
Ensembl chr 9:57,850,922...57,855,257
|
|
G |
TNF |
tumor necrosis factor |
increases expression |
EXP |
Ofloxacin results in increased expression of TNF mRNA; Ofloxacin results in increased expression of TNF protein |
CTD |
PMID:24582689 |
|
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
multiple interactions increases expression |
EXP |
TNFRSF1A mutant form inhibits the reaction [Ofloxacin results in increased expression of CASP8 mRNA]; TNFRSF1A mutant form inhibits the reaction [Ofloxacin results in increased expression of TRADD mRNA] Ofloxacin results in increased expression of TNFRSF1A mRNA; Ofloxacin results in increased expression of TNFRSF1A protein |
CTD |
PMID:24582689 |
|
NCBI chr27:38,641,837...38,654,693
Ensembl chr27:38,638,753...38,700,282
|
|
G |
TRADD |
TNFRSF1A associated via death domain |
multiple interactions increases expression |
EXP |
TNFRSF1A mutant form inhibits the reaction [Ofloxacin results in increased expression of TRADD mRNA] |
CTD |
PMID:24582689 |
|
NCBI chr 5:82,200,430...82,211,430
Ensembl chr 5:82,206,111...82,210,963
|
|
|
G |
ATP2A2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
affects expression multiple interactions |
EXP |
Ranolazine affects the expression of ATP2A2 protein [Ranolazine co-treated with Enalapril] affects the expression of ATP2A2 protein; [Ranolazine co-treated with Metoprolol] affects the expression of ATP2A2 protein |
CTD |
PMID:18820026 |
|
NCBI chr26:8,148,181...8,209,392
Ensembl chr26:8,148,236...8,209,388
|
|
G |
EGR1 |
early growth response 1 |
multiple interactions affects expression |
EXP |
[Ranolazine co-treated with Enalapril] affects the expression of EGR1 protein; [Ranolazine co-treated with Metoprolol] affects the expression of EGR1 protein Ranolazine affects the expression of EGR1 protein |
CTD |
PMID:18820026 |
|
NCBI chr11:26,046,195...26,049,806
Ensembl chr11:26,046,228...26,048,575
|
|
G |
GATA4 |
GATA binding protein 4 |
affects expression multiple interactions |
EXP |
Ranolazine affects the expression of GATA4 protein [Ranolazine co-treated with Enalapril] affects the expression of GATA4 protein; [Ranolazine co-treated with Metoprolol] affects the expression of GATA4 protein |
CTD |
PMID:18820026 |
|
NCBI chr25:26,126,172...26,211,474
Ensembl chr25:26,127,853...26,182,989
|
|
G |
NAB1 |
NGFI-A binding protein 1 |
affects expression multiple interactions |
EXP |
Ranolazine affects the expression of NAB1 protein [Ranolazine co-treated with Enalapril] affects the expression of NAB1 protein; [Ranolazine co-treated with Metoprolol] affects the expression of NAB1 protein |
CTD |
PMID:18820026 |
|
NCBI chr37:1,207,619...1,243,546
Ensembl chr37:1,207,638...1,241,610
|
|
G |
SLC8A1 |
solute carrier family 8 member A1 |
affects expression multiple interactions |
EXP |
Ranolazine affects the expression of SLC8A1 protein [Ranolazine co-treated with Enalapril] affects the expression of SLC8A1 protein; [Ranolazine co-treated with Metoprolol] affects the expression of SLC8A1 protein |
CTD |
PMID:18820026 |
|
NCBI chr17:32,004,207...32,381,399
Ensembl chr17:32,005,245...32,307,700
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
increases expression |
EXP |
Rifampin results in increased expression of ABCB1 mRNA; Rifampin results in increased expression of ABCB1 protein |
CTD |
PMID:22620706 |
|
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
|
|
G |
NR1I2 |
nuclear receptor subfamily 1 group I member 2 |
increases activity |
EXP |
Rifampin results in increased activity of NR1I2 protein |
CTD |
PMID:27732639 |
|
NCBI chr33:23,444,367...23,456,405
Ensembl chr33:23,432,690...23,455,347
|
|